Sichuan Goldstone Asia Pharmaceutical Inc. Overview
Sichuan Goldstone Asia Pharmaceutical Inc., a company based in Chengdu, China, specializes in the research, development, manufacturing, and sales of plastic composite pipe and vacuum coating machines. The company operates both domestically and internationally, offering a range of products including reinforced pipe equipment and vacuum coating equipment. It is listed on the Shenzhen Stock Exchange and trades under the currency CNY. As of May 20, 2025, the company’s close price was 8.98 CNY, with a 52-week high of 11.48 CNY on January 7, 2025, and a 52-week low of 6.71 CNY on April 8, 2025. The market capitalization stands at 3,217,968,762 CNY, and the price-to-earnings ratio is 56.0644.
Pharmaceutical Sector Activity
On May 22, 2025, the pharmaceutical sector showed significant activity, with several companies experiencing notable stock movements. According to reports from stock.eastmoney.com and 界面新闻, pharmaceutical stocks were active despite broader market trends. Notably, Huaixiang Pharmaceutical and Yong’an Pharmaceutical reached their daily price limits in the afternoon. Other companies such as Haisen Pharmaceutical, HaiChen Pharmaceutical, Lurong Pharmaceutical, and Jinshiya Pharmaceutical also saw substantial gains. Haisen Pharmaceutical had previously halted trading, indicating strong investor interest.
Investor Inquiries on RTP Equipment
On the same day, an investor inquiry was addressed by Jinshiya Pharmaceutical regarding their RTP (Reinforced Thermoplastic Pipe) equipment. The equipment is primarily used in the oil and gas industry for manufacturing medium to high-pressure flexible pipelines. The company’s financial research center responded to questions about profitability in the pharmaceutical, new materials, and machinery sectors for the first quarter. Additionally, inquiries about the prospects of the newly listed RTP equipment were addressed, highlighting investor interest in the company’s technological advancements.
Overall, while Sichuan Goldstone Asia Pharmaceutical Inc. is not directly mentioned in the pharmaceutical sector news, the broader industry activity and investor interest in related technologies underscore the dynamic nature of the market.